Get in touch
Questions about growing, workshops, the cooperative or partnerships? Send us a message and we will reply by email.
Prefer email? Write to erasmus@evec.org.gr
EVEC Microgreens
The therapeutic potential of red radish microgreens in modulating inflammation and cancer pathways
This review highlights the therapeutic potential of red radish microgreens (RRMs) as a nutrient-rich food with notable antioxidant, anti-inflammatory, and
Trina Ekawati Tallei, Nova Hellen Kapantow, Nurdjannah Jane Niode, Illah Sailah, Maghfirah Savitri, Muhammad Yamin Lahay, Jayanthi Barasarathi
CyTA – Journal of Food · 2025 · https://doi.org/10.1080/19476337.2025.2467410
Abstract
This review highlights the therapeutic potential of red radish microgreens (RRMs) as a nutrient-rich food with notable antioxidant, anti-inflammatory, and anticancer properties. Rich in bioactive compounds such as phenolic acids, flavonoids, glucosinolates, isothiocyanates, sulforaphane, and carotenoids, RRMs exhibit the ability to modulate key signaling pathways, including NF-κB, MAPK, JAK/STAT, TGF-β, SRC kinase, COX-2-PGE-2, and Wnt/β-catenin. These pathways regulate critical processes such as cell proliferation, angiogenesis, migration, and apoptosis, offering potential for inflammation and cancer mitigation. The review also explores the suitability of RRMs as space food, emphasizing their rapid growth, minimal resource requirements, and ability to support astronauts’ health by addressing oxidative stress, immune dysregulation, and inflammation in microgravity. While current evidence underscores their health-promoting effects, further in vitro and in vivo studies are essential to elucidate their molecular mechanisms and optimize their applications in medicine and space nutrition.
Licence and reuse
| Licence | CC-BY-NC-4.0 |
|---|---|
| May we host this PDF? | Yes |
| May we publish a plain-language summary? | Yes — this licence permits adaptations. |
| Commercial use permitted? | No — non-commercial use only |
| Share-alike required? | No |
How to credit this work
Trina Ekawati Tallei; Nova Hellen Kapantow; Nurdjannah Jane Niode; Illah Sailah; Maghfirah Savitri; Muhammad Yamin Lahay; Jayanthi Barasarathi (2025). The therapeutic potential of red radish microgreens in modulating inflammation and cancer pathways. CyTA – Journal of Food. https://doi.org/10.1080/19476337.2025.2467410 Licensed under Creative Commons Attribution NC 4.0 (https://creativecommons.org/licenses/by-nc/4.0/). Hosted by EVEC Athens (microgreens.org.gr). No changes were made to this article. Provided as-is, without warranties. EVEC Athens is not affiliated with, and this copy is not endorsed by, the authors or the publisher.
Explore this on our site
- How to grow it: Radish microgreens — growing guide
- Related reading: Broccoli microgreens and sulforaphane what the research shows
- Related reading: Microgreens and their anti inflammatory antioxidant and preventive potential
- Related reading: The antioxidant capacity of radish microgreens
- Related reading: Microgreens as the space food
About this copy
This is a copy of the published article, hosted by EVEC Athens for free educational use under its open licence. The permanent scientific reference is the DOI above. We have not altered the file in any way. If you are an author or rights holder and want this copy removed, please use our notice and takedown procedure. We acknowledge every request within five working days, and act within ten.
Co-funded by the European Union.
This portal presents the microgreens methodology; the organisation behind it is EVEC Athens — the European Voluntary and Educational Center (evec.org.gr). Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the granting authority can be held responsible for them.
Open licence. Except where stated otherwise, the educational materials on this portal are licensed under CC BY 4.0 — free to use, adapt and share, including commercially, with credit. See the licence terms.
Accessibility. We aim for WCAG 2.1 AA and publish what does and does not yet meet it — see the accessibility statement. If anything here blocks you, tell us and we will send the material in a format that works for you.